AM-6527

AM-6527
[[File:|frameless|220px|alt=|Chemical structure of AM-6527]]
INN
Drug class
Routes of administration	Oral
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status	Research chemical
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

AM-6527 is a synthetic cannabinoid that acts as a potent and selective CB1 receptor antagonist. It is primarily used in scientific research to study the endocannabinoid system and its role in various physiological processes.

Chemical Structure and Properties

AM-6527 is a member of the indole-based class of cannabinoids. Its chemical structure is characterized by a core indole moiety, which is a common feature among many synthetic cannabinoids. The specific modifications on the indole ring and the attached side chains confer its selectivity and potency as a CB1 receptor antagonist.

Mechanism of Action

AM-6527 functions by binding to the CB1 receptor, which is one of the two main receptors in the endocannabinoid system, the other being the CB2 receptor. Unlike CB1 receptor agonists that activate the receptor, AM-6527 blocks the receptor, preventing endogenous cannabinoids like anandamide from exerting their effects. This antagonistic action makes AM-6527 a valuable tool in research for understanding the role of CB1 receptors in various physiological and pathological processes.

Research Applications

AM-6527 is used extensively in preclinical studies to investigate the role of the CB1 receptor in:

• Pain management: By blocking CB1 receptors, researchers can study the contribution of the endocannabinoid system to pain perception and modulation.
• Appetite regulation: The CB1 receptor is known to play a role in appetite and energy balance, making AM-6527 useful in studies related to obesity and metabolic disorders.
• Neuroprotection: Research into neurodegenerative diseases often involves the use of CB1 antagonists to explore potential therapeutic avenues.

Pharmacokinetics

The pharmacokinetic profile of AM-6527, including its absorption, distribution, metabolism, and excretion, is not fully characterized in the literature. However, as a research chemical, it is typically administered in controlled laboratory settings, often via oral routes in animal models.

Safety and Toxicology

As with many research chemicals, the safety profile of AM-6527 is not well-documented. It is not approved for human use and should be handled with caution in laboratory settings. Researchers must adhere to appropriate safety protocols to minimize exposure and potential risks.

Legal Status

AM-6527 is classified as a research chemical and is not approved for medical use. Its legal status may vary by country, and researchers should ensure compliance with local regulations when conducting studies involving this compound.

Also see

• Cannabinoid receptor
• Endocannabinoid system
• CB1 receptor
• CB2 receptor
• Synthetic cannabinoids